Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in Chordoma

被引：30
|
作者：
Asquith, Christopher R. M. [1 ,2 ]
Naegeli, Kaleb M. [3 ]
East, Michael P. [2 ]
Laitinen, Tuomo [4 ]
Havener, Tammy M. [3 ]
Wells, Carrow I. [1 ]
Johnson, Gary L. [2 ]
Drewry, David H. [1 ]
Zuercher, William J. [1 ,5 ]
Morris, David C. [3 ]
机构：
[1] Univ N Carolina, UNC Eshelman Sch Pharm, Struct Genom Consortium, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, UNC Catalyst Rare Dis, Chapel Hill, NC 27599 USA
[4] Univ Eastern Finland, Fac Hlth Sci, Sch Pharm, Kuopio 70211, Finland
[5] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2019年 / 62卷 / 09期
基金：
加拿大创新基金会; 巴西圣保罗研究基金会;
关键词：
4-ANILINOQUINOLINES; EXPRESSION; MUTATIONS;
D O I：
10.1021/acs.jmedchem.9b00350
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
We describe the design of a set of inhibitors to investigate the relationship between cyclin G associated kinase (GAK) and epidermal growth factor receptor (EGFR) in chordoma bone cancers. These compounds were characterized both in vitro and using in cell target engagement assays. The most potent chordoma inhibitors were further characterized in a kinome-wide screen demonstrating narrow spectrum profiles. While we observed a direct correlation between EGFR and antiproliferative effects on chordoma, GAK inhibition appeared to have only a limited effect.
引用
收藏
页码：4772 / 4778
页数：7
相关论文
共 50 条
  • [31] Safety and Tolerability of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Oncology
    Rashmi R. Shah
    Devron R. Shah
    Drug Safety, 2019, 42 : 181 - 198
  • [32] A model for the inhibition of the epidermal growth factor receptor tyrosine kinase (EGFR TK) by Lavendustin A
    Clark, BP
    Groundwater, PW
    Mackay, SP
    ANNALS OF ONCOLOGY, 1998, 9 : 109 - 109
  • [33] Cutaneous adverse effects during therapy with an epidermal growth factor receptor (EGFR) inhibitor
    Santoro, Francesca
    Cozzani, Emanuele
    Parodi, Aurora
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2006, 17 (03) : 160 - 161
  • [34] Design of quinazolines targeting the epidermal growth factor receptor (EGFR) tyrosine kinase as potential inhibitors of angiogenesis.
    Ghosh, S
    Liu, XP
    Narla, RK
    Jun, X
    Mao, C
    Uckun, FM
    BLOOD, 1999, 94 (10) : 73B - 73B
  • [35] Inhibition of Cyclin G-Associated Kinase (GAK) Impairs Growth of Alveolar Type 2 Cells in a 3-Dimensional Culture System
    Bates, C. A.
    Zhao, B.
    Schlobohm, A.
    Asquith, C.
    Zuercher, W.
    Barkauskas, C. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [36] QSAR Study of Quinazoline Derivatives as Inhibitor of Epidermal Growth Factor Receptor-Tyrosine Kinase (EGFR-TK)
    Aman, La Ode
    Abdulkadir, Widisusanti
    Rembet, Julitha Geybie
    Tjahjono, Daryono H.
    PROCEEDINGS OF THE 3RD INTERNATIONAL CONFERENCE ON COMPUTATION FOR SCIENCE AND TECHNOLOGY, 2015, 5 : 114 - 119
  • [37] Neoadjuvant and adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer
    Zhai, Haoran
    Zhong, Wenzhao
    Yang, Xuening
    Wu, Yi-Long
    TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (01) : 82 - 93
  • [38] The Prediction Of Epidermal Growth Factor Receptor Mutation And Prognosis Of EGFR Tyrosine Kinase Inhibitor By Serum Ferritin In Advanced NSCLC
    Wu, Zhen
    Dai, Yu
    Chen, Liang-An
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 8835 - 8843
  • [39] Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer
    Schiff, BA
    McMurphy, AB
    Jasser, SA
    Younes, MN
    Doan, D
    Yigitbasi, OG
    Kim, SW
    Zhou, G
    Mandal, M
    Bekele, BN
    Holsinger, FC
    Sherman, SI
    Yeung, SC
    El-Naggar, AK
    Myers, JN
    CLINICAL CANCER RESEARCH, 2004, 10 (24) : 8594 - 8602
  • [40] Molecular predictors for epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs): role of egfr gene amplification
    Cappuzzo, Federico
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S156 - S157
12345